126 related articles for article (PubMed ID: 6303528)
1. [Purification of an endogenous inhibitor of sodium-potassium-ATPase].
Cloix JF; Miller ED; Pernollet MG; Devynck MA; Meyer P
C R Seances Acad Sci III; 1983 Feb; 296(5):213-6. PubMed ID: 6303528
[TBL] [Abstract][Full Text] [Related]
2. An Na, K ATPase inhibitor from ultrafiltrate obtained by hemodialysis of patients with uremia.
Sohn HJ; Stokes GS; Johnston H
J Lab Clin Med; 1992 Aug; 120(2):264-71. PubMed ID: 1323635
[TBL] [Abstract][Full Text] [Related]
3. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
[TBL] [Abstract][Full Text] [Related]
4. Na-K-ATPase inhibitor dissociated from hypertension-associated plasma protein.
Weiler EW; Khalil-Manesh F; Gonick HC; Prins BA; Purdy RE; Sensharma DK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):364-73. PubMed ID: 10232496
[TBL] [Abstract][Full Text] [Related]
5. [Affinity chromatographic study of the changes in the endogenous Na+-K+-ATPase inhibitor during sodium loading in man].
Cloix JF; Henning G; Crabos M; Delva P; Meyer P
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1251-5. PubMed ID: 6098236
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
7. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
[TBL] [Abstract][Full Text] [Related]
8. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
Gentile DA; Skoner DP
Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
[TBL] [Abstract][Full Text] [Related]
9. Effects of soybean lipoxygenase on Na+/K+-ATPase activity in vitro.
Kumarathasan R; Leenen FH
Can J Physiol Pharmacol; 2000 Sep; 78(9):691-5. PubMed ID: 11007531
[TBL] [Abstract][Full Text] [Related]
10. Effect of 5-hydroxytryptamine on sodium- and potassium-dependent adenosine triphosphatase and its reactivity toward ouabain.
Stepp LR; Novakoski MA
Arch Biochem Biophys; 1997 Jan; 337(1):43-53. PubMed ID: 8990266
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a competitive and reversible ligand to E2 conformation of Na, K ATPase molecule.
Rauch AL; Buckalew VM
Biochem Biophys Res Commun; 1988 Jan; 150(2):648-54. PubMed ID: 2829880
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
[TBL] [Abstract][Full Text] [Related]
13. Unconjugated bilirubin effect on 3H-ouabain binding to human fetal red cells.
Corchs JL; Corchs MJ; Serrani RE
Rev Esp Fisiol; 1994 Mar; 50(1):5-9. PubMed ID: 7991940
[TBL] [Abstract][Full Text] [Related]
14. Chemical, experimental, and clinical studies on endogenous ouabain-like substance in hypertension.
Cloix JF; Crabos M; Devynck MA; Elghozi JL; Henning G; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB
Adv Nephrol Necker Hosp; 1985; 14():161-71. PubMed ID: 2579533
[TBL] [Abstract][Full Text] [Related]
15. Endogenous "ouabain-like" activity in bovine plasma.
Tal DM; Katchalsky S; Lichtstein D; Karlish SJ
Biochem Biophys Res Commun; 1986 Feb; 135(1):1-8. PubMed ID: 3006675
[TBL] [Abstract][Full Text] [Related]
16. [Mammalian lignans: possible involvement in endogenous digitalis activity].
Braquet P; Senn N; Fagoo M; Garay R; Robin JP; Esanu A; Chabrier E; Godfrain T
C R Acad Sci III; 1986; 302(12):443-8. PubMed ID: 3013381
[TBL] [Abstract][Full Text] [Related]
17. Recent progress on an endogenous digitalislike factor in hypertension.
Cloix JF; Crabos M; Meyer P
J Clin Hypertens; 1986 Jun; 2(2):93-100. PubMed ID: 3020179
[TBL] [Abstract][Full Text] [Related]
18. [An inhibitor of nerve cell membrane Na,K-ATPase. Isolation and general characteristics].
Elaev NR; Baĭgil'dina AA
Biokhimiia; 1994 Mar; 59(3):389-94. PubMed ID: 8180271
[TBL] [Abstract][Full Text] [Related]
19. Evidence for tryptophan residues in the cation transport path of the Na(+),K(+)-ATPase.
Yudowski GA; Bar Shimon M; Tal DM; González-Lebrero RM; Rossi RC; Garrahan PJ; Beaugé LA; Karlish SJ
Biochemistry; 2003 Sep; 42(34):10212-22. PubMed ID: 12939149
[TBL] [Abstract][Full Text] [Related]
20. Individual variability in membrane sodium transport during salt loading--evidence against the production of a Na+-K+-ATPase inhibitor in hypertension.
Maling TJ; Siebers RW
Prog Biochem Pharmacol; 1988; 23():91-100. PubMed ID: 2847194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
